Mycophenolate mofetil is associated with less death with function than azathioprine in cadaveric renal transplantation
Open Access
- 1 June 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 18 (6) , 1197-1200
- https://doi.org/10.1093/ndt/gfg082
Abstract
Background. Dialysis patients have increased vascular calcification of the coronary arteries and aorta by electron beam CT scan. The purpose of the present study was to utilize an alternative machine, spiral CT, to assess calcification in end‐stage renal disease (ESRD) patients.Keywords
This publication has 6 references indexed in Scilit:
- INTERACTION OF MYCOPHENOLATE MOFETIL AND HLA MATCHING ON RENAL ALLOGRAFT SURVIVALTransplantation, 2001
- MYCOPHENOLATE MOFETIL REDUCES LATE RENAL ALLOGRAFT LOSS INDEPENDENT OF ACUTE REJECTIONTransplantation, 2000
- Functional graft survival: the significance of patient death with a functioning graftTransplantation Proceedings, 1998
- Cardiovascular complications after renal transplantationTransplantation Proceedings, 1998
- A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1996
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejectionThe Lancet, 1995